A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function

StatusRecruiting
PhaseNot applicable
SponsorBayer
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment increased: 50 → 58 participants
    • Eligibility criteria expanded, about 13 words
    • Site details revised
  2. Minor 4 versions Re-verified since Apr 16, 2026, no change to tracked fieldsv4-v7
  3. Minor Primary and study completion dates: Dec 22, 2026 to Feb 19, 2027v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 7, 2026 to Jan 6, 2026
    • Site details revised
    v2
  5. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
131 trials monitored
See 11 trials at risk
The main purpose of this study is to investigate how reliable a test assessing the renal functional reserve (RFR) and the maximum glomerular filtration rate (maxGFR) are. MaxGFR and RFR assessments are repeated twice at 1-month intervals. If precise, this test may improve the measure of kidney function and be useful in future studies for people with chronic kidney problems. To do this, the researchers will collect and analyze information about kidney function from up to 50 adults, including healthy people and people with stable kidney problems. Each person will come to the study center for a screening visit and then three study days, each about a month apart. On each study day, participants will have blood and urine samples taken before and after drinking a protein shake. The tests will measure things like creatinine, cystatin C, and other markers in the blood and urine to see how the kidneys are working. The study will also record basic health information, weight, blood pressure, and any medicines being taken. The study will last about 2 to 2.5 months for each participant.
Trial Details
NCT Number NCT07368712
Lead Sponsor Bayer
Conditions
(from sponsor)
Acute Kidney Injury, Renal Insufficiency
Related terms Acute Kidney Injury, Renal Insufficiency
Enrollment 58 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov